Organism name | Millettia pinnata |
---|---|
Genus | Millettia |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Millettia pinnata |
---|---|
Linked NCBI taxonomy ID | 56065 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005784
![]() |
Limocitrol 3-alpha-L-arabinopyranosyl-(1->3)-galactoside
/ 3-[(3-O-alpha-L-Arabinopyranosyl-beta-D-galactopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-4H-1-benzopyran-4-one |
No. 1 | No. 15 |
![]() |
||||
C00013904
![]() |
Rhamnetin 3-alpha-L-arabinopyranosyl-(1->3)-galactoside
/ Quercetin 7-methyl ether 3-alpha-L-arabinopyranosyl-(1->3)-galactoside / 3-[(3-O-alpha-L-arabinopyranosyl-beta-D-galactopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one |
No. 1 | No. 15 |
![]() |
||||
C00011167
![]() |
Pongamoside A
|
No. 2 | No. 15 |
![]() |
||||
C00011170
![]() |
Pongamoside D
|
No. 2 | No. 15 |
![]() |
||||
C00011169
![]() |
Pongamoside C
|
No. 2 | No. 15 |
![]() |
||||
C00011168
![]() |
Pongamoside B
|
No. 2 | No. 15 |
![]() |
||||
C00005786
![]() |
Limocitrol 3-[alpha-L-arabinopyranosyl-(1->3)[galactosyl-(1->6)]-galactoside]
|
No. 5 | No. 15 |
![]() |
||||
C00013907
![]() |
Rhamnetin 3-alpha-L-arabinopyranosyl-(1->3)-[galactosyl-(1->6)-galactoside]
/ Quercetin 7-methyl ether 3-alpha-L-arabinopyranosyl-(1->3)-[galactosyl-(1->6)-galactoside] / 3-[(O-alpha-L-arabinopyranosyl-(1->3)-O-[beta-D-galactopyranosyl-(1->6)]-beta-D-galactopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one |
No. 5 | No. 15 |
![]() |
||||
C00004584
![]() |
Fisetin tetramethyl ether
/ 3,7,3',4'-Tetramethoxyflavone |
CHEMBL575808
|
No. 8 | No. 15 |
![]() |
|||
C00004047
![]() |
Isopongaflavone
/ Candidin (Tephrosia) / 5-Methoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL454843
|
10 / 4 / 1 | No. 24 | No. 15 |
![]() |
||
C00005072
![]() |
Pongaflavone
/ Karanjachromene / 3-Methoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL2204384
|
No. 24 | No. 15 |
![]() |
|||
C00005082
![]() |
Pongachromene
/ 2-(1,3-Benzodioxol-5-yl)-3-methoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one / 3-Methoxy-8,8-dimethyl-2-[3,4-(methylenedioxy)phenyl]-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL573848
|
No. 24 | No. 15 |
![]() |
|||
C00004046
![]() |
Isopongachromene
|
No. 24 | No. 15 |
![]() |
||||
C00005049
![]() |
Kanugin
|
No. 27 | No. 15 |
![]() |
||||
C00005093
![]() |
3'-Methoxypongapin
|
No. 27 | No. 15 |
![]() |
||||
C00019200
![]() |
Pongaglabrone
/ Songaglabrene / 2-[3,4-(Methylenedioxy)phenyl]-4H-furo[2,3-h]-1-benzopyran-4-one |
CHEMBL583961
|
No. 27 | No. 15 |
![]() |
|||
C00005092
![]() |
Pongapin
/ 2-(1,3-Benzodioxol-5-yl)-3-methoxy-4H-furo[2,3-h]-1-benzopyran-4-one / 3-Methoxy-2-[3,4-(methylenedioxy)phenyl]-4H-furo[2,3-h]-1-benzopyran-4-one |
CHEMBL577397
|
No. 27 | No. 15 |
![]() |
|||
C00005045
![]() |
Demethoxykanugin
/ 2-(1,3-Benzodioxol-5-yl)-3,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL2205108
|
No. 27 | No. 15 |
![]() |
|||
C00020172
![]() |
5-Methoxy-3',4'-methylenedioxyfurano[2'',3'':7,8]flavone
|
No. 27 | No. 15 |
![]() |
||||
C00013534
![]() |
Ponganone XI
/ 6-Methoxy-7-phenyl-5H-furo[3,2-g][1]benzopyran-5-one |
No. 35 | No. 15 |
![]() |
||||
C00004049
![]() |
Pongone
/ 7-(3-Methoxyphenyl)-5H-furo[3,2-g][1]benzopyran-5-one |
CHEMBL224607
|
1 / 0 / 0 | No. 35 | No. 15 |
![]() |
||
C00019199
![]() |
Pongol
|
No. 35 | No. 15 |
![]() |
||||
C00019198
![]() |
Pongaglabol methyl ether
/ 5-Methoxyfurano[8,7-4'',5'']flavone |
No. 35 | No. 15 |
![]() |
||||
C00013453
![]() |
Millettocalyxin C
/ 2-(2,5-Dimethoxyphenyl)-4H-furo[2,3-h]-1-benzopyran-4-one |
No. 35 | No. 15 |
![]() |
||||
C00019196
![]() |
Pongapinnol D
|
No. 35 | No. 15 |
![]() |
||||
C00019195
![]() |
Pongapinnol C
|
No. 35 | No. 15 |
![]() |
||||
C00013448
![]() |
Cauliflorin A
/ Pongol methyl ether |
No. 35 | No. 15 |
![]() |
||||
C00013447
![]() |
2-(2-Methoxyphenyl)-4H-furo[2,3-h]-1-benzopyran-4-one
|
No. 35 | No. 15 |
![]() |
||||
C00019194
![]() |
Pongapinnol B
|
No. 35 | No. 15 |
![]() |
||||
C00019193
![]() |
Pongapinnol A
|
No. 35 | No. 15 |
![]() |
||||
C00013445
![]() |
Kanjone
/ 6-Methoxy-2-phenyl-4H-furo[2,3-h]-1-benzopyran-4-one |
No. 35 | No. 15 |
![]() |
||||
C00004050
![]() |
Glabone
|
CHEMBL223067
|
1 / 0 / 0 | No. 35 | No. 15 |
![]() |
||
C00013348
![]() |
3,7-Dimethoxyflavone
/ 3,7-Dimethoxy-2-phenyl-4H-1-benzopyran-4-one |
CHEMBL1449187
|
13 / 23 / 24 | No. 35 | No. 15 |
![]() |
||
C00013446
![]() |
9-Methoxy-7-phenyl-5H-furo[3,2-g][1]benzopyran-5-one
|
No. 35 | No. 15 |
![]() |
||||
C00005089
![]() |
Karanjin
/ 3-Methoxy-2-phenyl-4H-Furo[2,3-h]-1-benzopyran-4-one |
CHEMBL208484
|
C052068
|
20 / 21 / 18 | No. 35 | No. 15 |
![]() |
|
C00013443
![]() |
Pongaglabol
/ 5-Hydroxy-2-phenyl-4H-furo[2,3-h]-1-benzopyran-4-one |
No. 35 | No. 15 |
![]() |
||||
C00019016
![]() |
Lanceolatin B (flavonoid)
|
CHEMBL224157
|
1 / 0 / 0 | No. 35 | No. 15 |
![]() |
||
C00019197
![]() |
Pongacoumestan
/ 3,9-Dihydroxy-4-methoxycoumestan |
No. 54 | No. 17 |
![]() |
||||
C00006450
![]() |
Lanceolatin B
|
No. 88 |
![]() |
|||||
C00008132
![]() |
(-)-Isolonchocarpin
|
No. 127 | No. 14 |
![]() |
||||
C00008529
![]() |
Isoglabrachromene
|
No. 127 | No. 14 |
![]() |
||||
C00014233
![]() |
Ponganone III
/ (2S)-3',4'-Dimethoxy-6'',6''-dimethylpyrano[2'',3'':7,8]flavanone |
No. 127 | No. 14 |
![]() |
||||
C00014244
![]() |
Ponganone IV
/ (2S)-6,3',4'-Trimethoxy-6'',6''-dimethylpyrano[2'',3'':7,8]flavanone |
No. 127 | No. 14 |
![]() |
||||
C00007094
![]() |
Pongachalcone II
|
CHEMBL463206
|
1 / 0 / 0 | No. 130 |
![]() |
|||
C00007109
![]() |
Glabrachalcone
|
CHEMBL2043073
|
No. 130 |
![]() |
||||
C00007084
![]() |
Pongachalcone I
|
No. 130 |
![]() |
|||||
C00007034
![]() |
Glabrachromene II
|
No. 130 |
![]() |
|||||
C00007050
![]() |
Lonchocarpin
|
CHEMBL457644
|
1 / 2 / 0 | No. 130 |
![]() |
|||
C00014624
![]() |
Ponganone VIII
/ 3-(1,3-Benzodioxol-5-yl)-1-(5,8-dimethoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-methoxy-1-propanone |
No. 130 |
![]() |
|||||
C00014493
![]() |
7-Methoxypraecansone B
/ 6'',6''-Dimethylpyrano[2'',3'':4',3']-2',6',beta-trimethoxychalcone |
CHEMBL508495
|
No. 130 |
![]() |
||||
C00007014
![]() |
Pongapinone A
|
C077815
|
No. 130 |
![]() |
||||
C00007036
![]() |
Glabrachromene I
|
No. 130 |
![]() |
|||||
C00014488
![]() |
Ponganone VI
/ 6'',6''-Dimethylpyrano[2'',3'':4',3']-2'-hydroxy-3,4,5'-trimethoxychalcone |
No. 130 |
![]() |
|||||
C00013427
![]() |
Ovalifolin
/ 6-[(3-Methyl-2-butenyl)oxy]-2-phenyl-4H-furo[2,3-h]-1-benzopyran-4-one |
No. 354 |
![]() |
|||||
C00013429
![]() |
(9R,10S)-rel-(-)-9,10-bis(Acetyloxy)-9,10-dihydro-5-methoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one
|
CHEMBL453813
|
No. 646 |
![]() |
||||
C00014438
![]() |
Ponganone X
/ 3,4-Methylenedioxy-2',4',6'-trimethoxy-beta-hydroxychalcone |
No. 676 |
![]() |
|||||
C00014167
![]() |
Ponganone V
/ 7-Methoxy-6-O-prenyl-3',4'-methylenedioxyflavanone |
No. 765 |
![]() |
|||||
C00014602
![]() |
Ponganone VII
/ 2',4'-Dimethoxy-3,4-methylenedioxydihydrochalcone |
No. 882 |
![]() |
|||||
C00007018
![]() |
Pongamol
|
No. 1302 |
![]() |
|||||
C00007013
![]() |
Pongagallone B
|
No. 2151 |
![]() |
|||||
C00007003
![]() |
Pongagallone A
|
No. 2151 |
![]() |
|||||
C00014623
![]() |
Ponganone IX
/ 3-(1,3-Benzodioxol-5-yl)-3-methoxy-1-(4-methoxy-5-benzofuranyl)-1-propanone |
No. 2296 |
![]() |
|||||
C00007017
![]() |
Ovalitenone
|
No. 2296 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00004049 C00004050 C00005089 C00019016 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00004047 C00005089 C00013348 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00004047 C00005089 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00005089 C00013348 | 4 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00005089 C00013348 | 0 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005089 C00013348 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00005089 C00013348 | 3 / 3 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00004047 C00005089 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00004047 C00007050 | 2 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00005089 C00013348 | 2 / 2 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00004047 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00004047 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00013348 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00013348 | 2 / 3 |
O75496 | Geminin | Unclassified protein | C00004047 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00005089 | 0 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00005089 | 7 / 3 |
P11926 | Ornithine decarboxylase | Lyase | C00007094 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00005089 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00013348 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00005089 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00013348 | 3 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00005089 | 3 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005089 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00005089 | 1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005089 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00013348 | 6 / 4 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00004047 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00005089 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00005089 | 1 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00004047 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00013348 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00013348 | 1 / 2 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00005089 | 0 / 3 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00004047 | 1 / 1 |
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#114500 | Colorectal cancer; crc |
P84022
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|